+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Human Vaccines - Market Analysis, Trends, and Forecasts

  • ID: 338467
  • Report
  • February 2020
  • Region: Global
  • 158 Pages
  • Global Industry Analysts, Inc
1 of 2
Human Vaccines market worldwide is projected to grow by US$14.6 Billion, driven by a compounded growth of 6.1%. Pediatric, one of the segments analyzed and sized in this study, displays the potential to grow at over 5.9%. The shifting dynamics supporting this growth makes it critical for businesses in this space to keep abreast of the changing pulse of the market. Poised to reach over US$24.7 Billion by the year 2025, Pediatric will bring in healthy gains adding significant momentum to global growth.

Representing the developed world, the United States will maintain a 5.2% growth momentum. Within Europe, which continues to remain an important element in the world economy, Germany will add over US$516.6 Million to the region's size and clout in the next 5 to 6 years. Over US$446.8 Million worth of projected demand in the region will come from Rest of Europe markets. In Japan, Pediatric will reach a market size of US$1.3 Billion by the close of the analysis period. As the world’s second largest economy and the new game changer in global markets, China exhibits the potential to grow at 9% over the next couple of years and add approximately US$3.9 Billion in terms of addressable opportunity for the picking by aspiring businesses and their astute leaders. Presented in visually rich graphics are these and many more need-to-know quantitative data important in ensuring quality of strategy decisions, be it entry into new markets or allocation of resources within a portfolio. Several macroeconomic factors and internal market forces will shape growth and development of demand patterns in emerging countries in Asia-Pacific, Latin America and the Middle East. All research viewpoints presented are based on validated engagements from influencers in the market, whose opinions supersede all other research methodologies.

Competitors identified in this market include, among others,
  • ALK - Abelló A/S
  • Altimmune, Inc.
  • Astellas Pharma Inc.
  • Bavarian Nordic A/S
  • BiondVax Pharmaceuticals Ltd.
  • Bharat Biotech
  • GlaxoSmithKline Plc.
  • Hualan Biological Engineering Inc.
  • Janssen Pharmaceuticals Inc.
  • MedImmune
  • Merck Sharp & Dohme Corp.
  • Mitsubishi Tanabe Pharma
  • Pfizer Inc.
  • Sanofi Pasteur SA
  • Serum Institute of India Pvt. Ltd.
  • Seqirus
  • SK BioScience
  • Takeda Pharmaceutical Company Limited
  • Zydus Cadila
Note: Product cover images may vary from those shown
2 of 2

I. INTRODUCTION, METHODOLOGY & REPORT SCOPE

II. EXECUTIVE SUMMARY

1. MARKET OVERVIEW

Human Vaccines: A Prelude

Recent Market Activity

Competitive Scenario

Vaccine Pricing: A Review

Global Competitor Market Shares

Human Vaccines Competitor Market Share Scenario Worldwide (in %): 2020 & 2029

2. FOCUS ON SELECT PLAYERS

ALK - Abelló A/S (Denmark)

Altimmune, Inc. (USA)

Astellas Pharma Inc. (Tokyo)

Bavarian Nordic (Denmark)

BiondVax Pharmaceuticals Ltd. (Israel)

Bharat Biotech (India)

GlaxoSmithKline Plc. (UK)

Hualan Biological Engineering Inc. (China)

Janssen Pharmaceuticals, Inc. (USA)

MedImmune (USA)

Merck Sharp & Dohme Corp., (USA)

Mitsubishi Tanabe Pharma Corporate (Japan)

Pfizer, Inc. (USA)

Sanofi Pasteur SA (France)

Serum Institute of India Pvt. Ltd. (India)

Seqirus (UK)

SK BioScience (Korea)

Takeda Pharmaceutical Company Limited (Japan)

Zydus Cadila (India)

3. MARKET TRENDS & DRIVERS

Combination Vaccines Market Driven by Fast Expanding Pediatric Population

List of Combination Vaccines in the US: 2018

Gardasil 9 Offers Protection against HPV for Expanded Age Group

Increasing Demand for Recombinant Vaccines

Global Cholera Vaccines Market

Further Clinical Trials Needed for an Effective Zika Vaccine

Merck’s rVSV-ZEBOV Ebola Vaccine used for Ring Vaccination in Congo

Rising Dengue Cases Drive Vaccines Demand

Sanofi’s Dengue Vaccine First-to-Market

EMA Recommends Approval of Dengue Vaccine

Vaccine for AIDS

Staggering Global Statistics of AIDS - Opportunity Indicator

Toxoid Vaccines Market

H1N1 Vaccines Market

HSV Vaccine on the Horizon

Rising Disease Incidence and Increasing Awareness Drive the Global Meningococcal Vaccines Market

BCG Vaccines

Key TB Vaccine Candidates in the Pipeline: 2018

New Vaccine for Herpes Zoster or Shingles

Two-dose Hepatitis B Vaccine for Adults

Global Rotavirus Vaccines Market

Typhoid Vaccines Market

Measles Vaccines Market

DNA Vaccines: Engineering Growth

Mobile Money Encourages Parents for Vaccinating Children

Noninjectable Vaccines: Gain without Pain

Application of Botulinum Toxin as Delivery Mechanism for Oral Vaccines

Novel Technologies Ensure Timely Vaccine Delivery for Patients in Remote Locations

Smart mRNA Vaccines

Growing Pricing Pressure - A Major Market Deterrent

Safety Issues Come to the Fore

Novel Vaccination Guidelines Mitigate Risks Associated with Developing Shoulder Injuries

BioWarfare: Threat Perception and Preparedness

Overview of Potential Bio-Terrorist Agents

Smallpox (Variola Major)

Anthrax (Bacillus Anthracis)

Plague (Yersinia Pestis)

Botulism (Clostridium Botulinum)

Tularemia (Francisella Tularensis)

Tackling Cold Chain Issues

Trade Statistics

Growing Incidence of Infectious Diseases Drives the Global Human Vaccines Market

Total Number of Infectious Disease Covered under Vaccination

Conjugate Vaccines Rule in Human Vaccines Market

Pneumococcal Vaccines – A Major Segment

Vaccine Pipeline by Major Companies

GSK Vaccine Pipeline

Merck Vaccines Pipeline

Pfizer Vaccines Pipeline

Sanofi Vaccines Portfolio

Emergent BioSolutions Inc. - Vaccine Pipeline

Astellas Pharma - Vaccines

Pediatric Vaccines Dominate the Human Vaccines Market

Select Pediatric Vaccines

Adults Vaccine Market to Witness Rapid Growth, Driven by Government Initiatives

Select Adult Vaccines

Developed Markets Dominate, Emerging Regions to Exhibit the Fastest Growth

Pneumococcal Vaccines Market Set to Witness Rapid Growth

Influenza Vaccines Market: A High Growth Segment

Cancer Vaccines Market Offers Potential Opportunities

4. GLOBAL MARKET PERSPECTIVE

TABLE 1: Human Vaccines Global Market Estimates and Forecasts in US$ Million by Region/Country: 2018-2025

TABLE 2: Human Vaccines Global Retrospective Market Scenario in US$ Million by Region/Country: 2009-2017

TABLE 3: Human Vaccines Market Share Shift across Key Geographies Worldwide: 2009 VS 2019 VS 2025

TABLE 4: Pediatric (Product Segment) World Market by Region/Country in US$ Million: 2018 to 2025

TABLE 5: Pediatric (Product Segment) Historic Market Analysis by Region/Country in US$ Million: 2009 to 2017

TABLE 6: Pediatric (Product Segment) Market Share Breakdown of Worldwide Sales by Region/Country: 2009 VS 2019 VS 2025

TABLE 7: Adult (Product Segment) Potential Growth Markets Worldwide in US$ Million: 2018 to 2025

TABLE 8: Adult (Product Segment) Historic Market Perspective by Region/Country in US$ Million: 2009 to 2017

TABLE 9: Adult (Product Segment) Market Sales Breakdown by Region/Country in Percentage: 2009 VS 2019 VS 2025

III. MARKET ANALYSIS

GEOGRAPHIC MARKET ANALYSIS

UNITED STATES

Market Facts & Figures

US Human Vaccines Market Share (in %) by Company: 2020 & 2025

Market Analytics

TABLE 10: United States Human Vaccines Market Estimates and Projections in US$ Million by Product Segment: 2018 to 2025

TABLE 11: Human Vaccines Market in the United States by Product Segment: A Historic Review in US$ Million for 2009-2017

TABLE 12: United States Human Vaccines Market Share Breakdown by Product Segment: 2009 VS 2019 VS 2025

CANADA

TABLE 13: Canadian Human Vaccines Market Estimates and Forecasts in US$ Million by Product Segment: 2018 to 2025

TABLE 14: Canadian Human Vaccines Historic Market Review by Product Segment in US$ Million: 2009-2017

TABLE 15: Human Vaccines Market in Canada: Percentage Share Breakdown of Sales by Product Segment for 2009, 2019, and 2025

JAPAN

TABLE 16: Japanese Market for Human Vaccines: Annual Sales Estimates and Projections in US$ Million by Product Segment for the Period 2018-2025

TABLE 17: Human Vaccines Market in Japan: Historic Sales Analysis in US$ Million by Product Segment for the Period 2009-2017

TABLE 18: Japanese Human Vaccines Market Share Analysis by Product Segment: 2009 VS 2019 VS 2025

CHINA

TABLE 19: Chinese Human Vaccines Market Growth Prospects in US$ Million by Product Segment for the Period 2018-2025

TABLE 20: Human Vaccines Historic Market Analysis in China in US$ Million by Product Segment: 2009-2017

TABLE 21: Chinese Human Vaccines Market by Product Segment: Percentage Breakdown of Sales for 2009, 2019, and 2025

EUROPE

Market Facts & Figures

European Human Vaccines Market: Competitor Market Share Scenario (in %) for 2020 & 2025

Market Analytics

TABLE 22: European Human Vaccines Market Demand Scenario in US$ Million by Region/Country: 2018-2025

TABLE 23: Human Vaccines Market in Europe: A Historic Market Perspective in US$ Million by Region/Country for the Period 2009-2017

TABLE 24: European Human Vaccines Market Share Shift by Region/Country: 2009 VS 2019 VS 2025

TABLE 25: European Human Vaccines Market Estimates and Forecasts in US$ Million by Product Segment: 2018-2025

TABLE 26: Human Vaccines Market in Europe in US$ Million by Product Segment: A Historic Review for the Period 2009-2017

TABLE 27: European Human Vaccines Market Share Breakdown by Product Segment: 2009 VS 2019 VS 2025

FRANCE

TABLE 28: Human Vaccines Market in France by Product Segment: Estimates and Projections in US$ Million for the Period 2018-2025

TABLE 29: French Human Vaccines Historic Market Scenario in US$ Million by Product Segment: 2009-2017

TABLE 30: French Human Vaccines Market Share Analysis by Product Segment: 2009 VS 2019 VS 2025

GERMANY

TABLE 31: Human Vaccines Market in Germany: Recent Past, Current and Future Analysis in US$ Million by Product Segment for the Period 2018-2025

TABLE 32: German Human Vaccines Historic Market Analysis in US$ Million by Product Segment: 2009-2017

TABLE 33: German Human Vaccines Market Share Breakdown by Product Segment: 2009 VS 2019 VS 2025

ITALY

TABLE 34: Italian Human Vaccines Market Growth Prospects in US$ Million by Product Segment for the Period 2018-2025

TABLE 35: Human Vaccines Historic Market Analysis in Italy in US$ Million by Product Segment: 2009-2017

TABLE 36: Italian Human Vaccines Market by Product Segment: Percentage Breakdown of Sales for 2009, 2019, and 2025

UNITED KINGDOM

TABLE 37: United Kingdom Market for Human Vaccines: Annual Sales Estimates and Projections in US$ Million by Product Segment for the Period 2018-2025

TABLE 38: Human Vaccines Market in the United Kingdom: Historic Sales Analysis in US$ Million by Product Segment for the Period 2009-2017

TABLE 39: United Kingdom Human Vaccines Market Share Analysis by Product Segment: 2009 VS 2019 VS 2025

SPAIN

TABLE 40: Spanish Human Vaccines Market Estimates and Forecasts in US$ Million by Product Segment: 2018 to 2025

TABLE 41: Spanish Human Vaccines Historic Market Review by Product Segment in US$ Million: 2009-2017

TABLE 42: Human Vaccines Market in Spain: Percentage Share Breakdown of Sales by Product Segment for 2009, 2019, and 2025

RUSSIA

TABLE 43: Russian Human Vaccines Market Estimates and Projections in US$ Million by Product Segment: 2018 to 2025

TABLE 44: Human Vaccines Market in Russia by Product Segment: A Historic Review in US$ Million for 2009-2017

TABLE 45: Russian Human Vaccines Market Share Breakdown by Product Segment: 2009 VS 2019 VS 2025

REST OF EUROPE

TABLE 46: Rest of Europe Human Vaccines Market Estimates and Forecasts in US$ Million by Product Segment: 2018-2025

TABLE 47: Human Vaccines Market in Rest of Europe in US$ Million by Product Segment: A Historic Review for the Period 2009-2017

TABLE 48: Rest of Europe Human Vaccines Market Share Breakdown by Product Segment: 2009 VS 2019 VS 2025

ASIA-PACIFIC

TABLE 49: Asia-Pacific Human Vaccines Market Estimates and Forecasts in US$ Million by Region/Country: 2018-2025

TABLE 50: Human Vaccines Market in Asia-Pacific: Historic Market Analysis in US$ Million by Region/Country for the Period 2009-2017

TABLE 51: Asia-Pacific Human Vaccines Market Share Analysis by Region/Country: 2009 VS 2019 VS 2025

TABLE 52: Human Vaccines Market in Asia-Pacific by Product Segment: Estimates and Projections in US$ Million for the Period 2018-2025

TABLE 53: Asia-Pacific Human Vaccines Historic Market Scenario in US$ Million by Product Segment: 2009-2017

TABLE 54: Asia-Pacific Human Vaccines Market Share Analysis by Product Segment: 2009 VS 2019 VS 2025

AUSTRALIA

TABLE 55: Human Vaccines Market in Australia: Recent Past, Current and Future Analysis in US$ Million by Product Segment for the Period 2018-2025

TABLE 56: Australian Human Vaccines Historic Market Analysis in US$ Million by Product Segment: 2009-2017

TABLE 57: Australian Human Vaccines Market Share Breakdown by Product Segment: 2009 VS 2019 VS 2025

INDIA

TABLE 58: Indian Human Vaccines Market Estimates and Forecasts in US$ Million by Product Segment: 2018 to 2025

TABLE 59: Indian Human Vaccines Historic Market Review by Product Segment in US$ Million: 2009-2017

TABLE 60: Human Vaccines Market in India: Percentage Share Breakdown of Sales by Product Segment for 2009, 2019, and 2025

SOUTH KOREA

TABLE 61: Human Vaccines Market in South Korea: Recent Past, Current and Future Analysis in US$ Million by Product Segment for the Period 2018-2025

TABLE 62: South Korean Human Vaccines Historic Market Analysis in US$ Million by Product Segment: 2009-2017

TABLE 63: Human Vaccines Market Share Distribution in South Korea by Product Segment: 2009 VS 2019 VS 2025

REST OF ASIA-PACIFIC

TABLE 64: Rest of Asia-Pacific Market for Human Vaccines: Annual Sales Estimates and Projections in US$ Million by Product Segment for the Period 2018-2025

TABLE 65: Human Vaccines Market in Rest of Asia-Pacific: Historic Sales Analysis in US$ Million by Product Segment for the Period 2009-2017

TABLE 66: Rest of Asia-Pacific Human Vaccines Market Share Analysis by Product Segment: 2009 VS 2019 VS 2025

LATIN AMERICA

TABLE 67: Latin American Human Vaccines Market Trends by Region/Country in US$ Million: 2018-2025

TABLE 68: Human Vaccines Market in Latin America in US$ Million by Region/Country: A Historic Perspective for the Period 2009-2017

TABLE 69: Latin American Human Vaccines Market Percentage Breakdown of Sales by Region/Country: 2009, 2019, and 2025

TABLE 70: Latin American Human Vaccines Market Growth Prospects in US$ Million by Product Segment for the Period 2018-2025

TABLE 71: Human Vaccines Historic Market Analysis in Latin America in US$ Million by Product Segment: 2009-2017

TABLE 72: Latin American Human Vaccines Market by Product Segment: Percentage Breakdown of Sales for 2009, 2019, and 2025

ARGENTINA

TABLE 73: Argentinean Human Vaccines Market Estimates and Forecasts in US$ Million by Product Segment: 2018-2025

TABLE 74: Human Vaccines Market in Argentina in US$ Million by Product Segment: A Historic Review for the Period 2009-2017

TABLE 75: Argentinean Human Vaccines Market Share Breakdown by Product Segment: 2009 VS 2019 VS 2025

BRAZIL

TABLE 76: Human Vaccines Market in Brazil by Product Segment: Estimates and Projections in US$ Million for the Period 2018-2025

TABLE 77: Brazilian Human Vaccines Historic Market Scenario in US$ Million by Product Segment: 2009-2017

TABLE 78: Brazilian Human Vaccines Market Share Analysis by Product Segment: 2009 VS 2019 VS 2025

MEXICO

TABLE 79: Human Vaccines Market in Mexico: Recent Past, Current and Future Analysis in US$ Million by Product Segment for the Period 2018-2025

TABLE 80: Mexican Human Vaccines Historic Market Analysis in US$ Million by Product Segment: 2009-2017

TABLE 81: Mexican Human Vaccines Market Share Breakdown by Product Segment: 2009 VS 2019 VS 2025

REST OF LATIN AMERICA

TABLE 82: Rest of Latin America Human Vaccines Market Estimates and Projections in US$ Million by Product Segment: 2018 to 2025

TABLE 83: Human Vaccines Market in Rest of Latin America by Product Segment: A Historic Review in US$ Million for 2009-2017

TABLE 84: Rest of Latin America Human Vaccines Market Share Breakdown by Product Segment: 2009 VS 2019 VS 2025

MIDDLE EAST

TABLE 85: The Middle East Human Vaccines Market Estimates and Forecasts in US$ Million by Region/Country: 2018-2025

TABLE 86: Human Vaccines Market in the Middle East by Region/Country in US$ Million: 2009-2017

TABLE 87: The Middle East Human Vaccines Market Share Breakdown by Region/Country: 2009, 2019, and 2025

TABLE 88: The Middle East Human Vaccines Market Estimates and Forecasts in US$ Million by Product Segment: 2018 to 2025

TABLE 89: The Middle East Human Vaccines Historic Market by Product Segment in US$ Million: 2009-2017

TABLE 90: Human Vaccines Market in the Middle East: Percentage Share Breakdown of Sales by Product Segment for 2009, 2019, and 2025

IRAN

TABLE 91: Iranian Market for Human Vaccines: Annual Sales Estimates and Projections in US$ Million by Product Segment for the Period 2018-2025

TABLE 92: Human Vaccines Market in Iran: Historic Sales Analysis in US$ Million by Product Segment for the Period 2009-2017

TABLE 93: Iranian Human Vaccines Market Share Analysis by Product Segment: 2009 VS 2019 VS 2025

ISRAEL

TABLE 94: Israeli Human Vaccines Market Estimates and Forecasts in US$ Million by Product Segment: 2018-2025

TABLE 95: Human Vaccines Market in Israel in US$ Million by Product Segment: A Historic Review for the Period 2009-2017

TABLE 96: Israeli Human Vaccines Market Share Breakdown by Product Segment: 2009 VS 2019 VS 2025

SAUDI ARABIA

TABLE 97: Saudi Arabian Human Vaccines Market Growth Prospects in US$ Million by Product Segment for the Period 2018-2025

TABLE 98: Human Vaccines Historic Market Analysis in Saudi Arabia in US$ Million by Product Segment: 2009-2017

TABLE 99: Saudi Arabian Human Vaccines Market by Product Segment: Percentage Breakdown of Sales for 2009, 2019, and 2025

UNITED ARAB EMIRATES

TABLE 100: Human Vaccines Market in the United Arab Emirates: Recent Past, Current and Future Analysis in US$ Million by Product Segment for the Period 2018-2025

TABLE 101: United Arab Emirates Human Vaccines Historic Market Analysis in US$ Million by Product Segment: 2009-2017

TABLE 102: Human Vaccines Market Share Distribution in United Arab Emirates by Product Segment: 2009 VS 2019 VS 2025

REST OF MIDDLE EAST

TABLE 103: Human Vaccines Market in Rest of Middle East: Recent Past, Current and Future Analysis in US$ Million by Product Segment for the Period 2018-2025

TABLE 104: Rest of Middle East Human Vaccines Historic Market Analysis in US$ Million by Product Segment: 2009-2017

TABLE 105: Rest of Middle East Human Vaccines Market Share Breakdown by Product Segment: 2009 VS 2019 VS 2025

AFRICA

TABLE 106: African Human Vaccines Market Estimates and Projections in US$ Million by Product Segment: 2018 to 2025

TABLE 107: Human Vaccines Market in Africa by Product Segment: A Historic Review in US$ Million for 2009-2017

TABLE 108: African Human Vaccines Market Share Breakdown by Product Segment: 2009 VS 2019 VS 2025

IV. COMPETITION

Total Companies Profiled: 66

Note: Product cover images may vary from those shown
3 of 2

Loading
LOADING...

Adroll
adroll